Galectin Therapeutics Inc (NASDAQ:GALT)

3.08
Delayed Data
As of May 06
 +0.13 / +4.41%
Today’s Change
2.79
Today|||52-Week Range
16.55
-11.24%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Czirr James C
Executive Chairman
Sale1/31/201593,168$3.22$300.0K-4.35%
Czirr James C
Executive Chairman
Buy1/31/2015166,667$1.80$300.0K-4.35%
Martin Rod D
Director
Buy5/13/201483,334$1.80$150.0K-73.49%
Traber Peter G
President & Chief Executive Officer
Buy8/14/20142,000$4.48$9.0K-33.19%
Traber Peter G
President & Chief Executive Officer
Buy8/14/20142,000$4.44$8.9K-33.19%
Freeman Kevin D
Director
Buy8/15/20141,000$4.70$4.7K-35.56%
Greenberg Arthur R
Director
Buy8/19/20141,000$4.56$4.6K-32.75%
Callicutt Jack W
Chief Financial Officer
Buy8/14/20141,000$4.55$4.6K-33.19%
Traber Peter G
President & Chief Executive Officer
Buy8/13/20141,000$4.42$4.4K-29.68%
Amelio Gilbert Frank
Director
Sale12/15/2014110$3.69$405.90-12.75%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account